Cancer Distress Management Program for Liver and Biliary Cancer within a SPORE

Overview

About this study

The aim of this study is to develop a feasible, acceptable, and sustainable comprehensive cancer distress management program that is tailored to the unique needs of cancer patient survivors.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who have received care for hepatobiliary cancer at Mayo Clinic in the past 5 years.
  • Caregiver of above patient.
  • Clinician providing care for hepatobiliary cancer patients at Mayo Clinic.
  • Member of SPORE Patient Advocacy Board.

Exclusion Criteria: 

  • Inability to complete an English language electronic survey for any reason. Non-English speaking patients will be offered translation services when available.

Eligibility last updated 12/15/21. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shawna Ehlers, Ph.D., L.P.

Open for enrollment

Contact information:

Shawna Ehlers Ph.D., L.P.

Ehlers.Shawna@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions